4:31 PM ET
8-K
Shareholder Meeting
Citius Oncology Shareholder Meeting
Citius Oncology, Inc. held its 2026 Annual Meeting of Stockholders on September 29, 2026. Stockholders elected three Class II directors (Dr. Eugene Holuka, Robert Smith, and Carol Webb) for three-year terms and ratified Wolf & Company, P.C. as the company's independent registered public accounting firm for the fiscal year ending September 30, 2026.